ICAM1 and plasma cell myeloma: The ICAM-1 monoclonal antibody UV3, an anti–human CD54 antibody, has also been found to inhibit the growth of multiple myeloma, lymphoma, uveal melanoma, breast cancer, prostate cancer, non–small cell lung cancer, and pancreatic cancer in severe combined immunodeficiency mice [7].